Esthesioneuroblastoma physical examination: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Mahshid)
 
(7 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==
==Overview==
Common physical examination findings of esthesioneuroblastoma include a reddish-gray, polypoid mass located in the upper nasal fossa, [[epistaxis]], nasal discharge, nasal pain, facial [[swelling]], [[trismus]], [[proptosis]], [[diplopia]], [[anosmia]], serous [[otitis media]], [[cervical]] [[lymphadenopathy]], [[retropharyngeal]] [[lymphadenopathy]], decreased visual acuity, extraocular movement paralysis, [[altered mental status]], and frontal [[headaches]].


==Physical Examination==
==Physical Examination==
In majority of cases, malignancy is not considered until secondary symptoms such as deformity or cranial nerve impairment and facial pain are observed. A patient with a recurrent [[epistaxis]] and/or unilateral nasal obstruction lasting longer than 1-2 months should undergo a thorough nasal evaluation by an otolaryngologist.
===HEENT===
===HEENT===
*Reddish-gray, polypoid mass located in the upper nasal fossa  
*Reddish-gray, polypoid mass located in the upper nasal fossa  
*Epistaxis
*[[Epistaxis]]
*Nasal discharge
*Nasal discharge
*Nasal pain
*Nasal pain
*Facial pain
*Facial pain
*Facial swelling
*Facial [[swelling]]
*Facial anesthesia
*Facial anesthesia
*Trismus
*[[Trismus]]
*Proptosis
*[[Proptosis]]
*Diplopia
*[[Diplopia]]
*Ear pain
*Ear pain
*Serous otitis media
*Serous [[otitis media]]
*Anosmia
*[[Anosmia]]
*Hyposmia
*[[Hyposmia]]
 
===Neck===
===Neck===
*Cervical lymphadenopathy
*[[Cervical]] [[lymphadenopathy]]
*Retropharyngeal lymphadenopathy
*[[Retropharyngeal]] [[lymphadenopathy]]
 
===Neuromuscular===
===Neuromuscular===
*Decreased visual acuity
*Decreased visual acuity
*Extraocular movement paralysis
*Extraocular movement paralysis
*Frontal headache
*Frontal [[headaches]]
*Altered mental status
*[[Altered mental status]]
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{Central nervous system tumors}}


[[Category:Disease]]
[[Category:Disease]]
Line 37: Line 40:
[[Category:neurology]]
[[Category:neurology]]
[[Category:Rhinology]]
[[Category:Rhinology]]
[[Category:Needs content]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 23:18, 26 November 2017

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma physical examination

CDC on Esthesioneuroblastoma physical examination

Esthesioneuroblastoma physical examination in the news

Blogs on Esthesioneuroblastoma physical examination

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Common physical examination findings of esthesioneuroblastoma include a reddish-gray, polypoid mass located in the upper nasal fossa, epistaxis, nasal discharge, nasal pain, facial swelling, trismus, proptosis, diplopia, anosmia, serous otitis media, cervical lymphadenopathy, retropharyngeal lymphadenopathy, decreased visual acuity, extraocular movement paralysis, altered mental status, and frontal headaches.

Physical Examination

In majority of cases, malignancy is not considered until secondary symptoms such as deformity or cranial nerve impairment and facial pain are observed. A patient with a recurrent epistaxis and/or unilateral nasal obstruction lasting longer than 1-2 months should undergo a thorough nasal evaluation by an otolaryngologist.

HEENT

Neck

Neuromuscular

References

Template:WH Template:WS